2.10. Stable angina, acute coronary syndromes and fibrinolysis
2.10.1. Management of stable angina and acute coronary syndromes
2.10.2. Fibrinolytic drugs
The fibrinolytic treatment of acute ischaemic stroke is restricted to specialist centres with adequate resources and appropriate expertise and in accordance with detailed protocols. The thrombolytic treatment of occluded central venous access devices including those used for haemodialysisis restricted to second line use after urokinase.
It should be noted that different alteplase preparations have different licensed indications